SUCAMPO PHARMACEUTICALS, INC. Finite-Lived Intangible Asset, Expected Amortization, Year Five

SUCAMPO PHARMACEUTICALS, INC. Finite-Lived Intangible Asset, Expected Amortization, Year Five

SUCAMPO PHARMACEUTICALS, INC. had Finite-Lived Intangible Asset, Expected Amortization, Year Five of $4.01 million as of 2016-12-31, per its 10-K filed 2017-03-08.

Discontinued › Notes › Intangible Assets › Goodwill and Other › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity

us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive · last filed 2017-03-08

• 2016-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year Five $4.01M.
• 2015-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year Five $22.69M.